Market Cap 238.03M
Revenue (ttm) 16.10M
Net Income (ttm) -42.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -264.41%
Debt to Equity Ratio 0.09
Volume 262,600
Avg Vol 96,604
Day's Range N/A - N/A
Shares Out 36.34M
Stochastic %K 30%
Beta 0.73
Analysts Strong Sell
Price Target $11.12

Company Profile

Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue....

Industry: Medical Devices
Sector: Healthcare
Phone: 647 476 1350
Fax: 647 847 3739
Address:
2400 Skymark Avenue, Unit 6, Mississauga, Canada
alexpitti
alexpitti Aug. 18 at 2:44 PM
$PROF cfo resigns, new software. stock spikes
0 · Reply
BioTuesdays
BioTuesdays Aug. 17 at 3:53 PM
$PROF has announced the introduction of its latest Treatment Delivery Consol (TDC) software being deployed across Profound’s TULSA-PRO-installed base. https://biotuesdays.com/2026/08/17/profounds-new-real-time-interventional-mri-software-to-pave-the-way-for-full-tulsa-days/
0 · Reply
alexpitti
alexpitti Aug. 15 at 12:48 AM
This is so so ugly. $PROF cfo resigns immediately Friday night dump
1 · Reply
BioTuesdays
BioTuesdays Aug. 14 at 3:38 PM
$PROF has announced the launch of Let’s Huddle, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey. https://biotuesdays.com/2026/08/14/profound-launches-lets-huddle-a-global-community-supporting-men-through-prostate-care/
0 · Reply
Bravosatya
Bravosatya Aug. 10 at 8:26 PM
$PROF more adoption news - Doctors are talking on TV shows- https://x.com/bravosatya/status/2086911268427092413?s=46
0 · Reply
johntarlick
johntarlick Aug. 7 at 2:49 PM
$PROF All indications are that prospects continue to be bright here. but i just can't understand the little games, like trying to score credit for delayed shipments or converting the pipeline into a dollar figure, or lumping sono-alleve into the pipeline to make it look slightly bigger. Indeed, it's the first use of the verb 'dollarizing' that i've ever seen. there's already a lot of lingo on quarterly calls, and when i hear someone say 'dollarizing' with a straight face, i'm disinclined to value that expertise. why can't they just be straightforward about this stuff? the news is generally good, it may not yet be the 'hockey stick' they've long boosted, but slow and steady is also good news.
3 · Reply
Bravosatya
Bravosatya Aug. 7 at 12:13 PM
$PROF just posted an article on my thoughts on the challenges faced by $PROF . checkout my X post and follow me on X for more content. https://x.com/bravosatya/status/2085700225662873759?s=46
0 · Reply
Bravosatya
Bravosatya Aug. 6 at 11:01 PM
$PROF if you guys missed today’s conference call - I have summarized my key takeaways of the call on my X account . Please check and follow for more updates. I have been following and posting on $PROF for a longtime now. I also posted on Q2 Earnings Report. https://x.com/bravosatya/status/2085500786822488132?s=46
1 · Reply
alexpitti
alexpitti Aug. 6 at 10:53 PM
$PROF bad naughty report
0 · Reply
alexpitti
alexpitti Aug. 6 at 10:52 PM
$DCTH did well $RCEL did well $APYX did fine $SI did spectacularly. $PROF did things we don't want to say lol
0 · Reply
Latest News on PROF
Profound Medical Announces Management Change

Fri, 14 Aug 2026 16:30:00 -0400 - 4 days ago

Profound Medical Announces Management Change


Profound Medical (PROF) Q2 2026 Earnings Call Transcript

2026-08-13T23:24:24.000Z - 5 days ago

Profound Medical (PROF) Q2 2026 Earnings Call Transcript


Profound Medical Q2 Earnings Call Highlights

Fri, 07 Aug 2026 05:05:49 -0400 - 12 days ago

Profound Medical Q2 Earnings Call Highlights


Profound Medical (PROF) Q2 Earnings Surpass Estimates

2026-08-07T02:35:03.000Z - 12 days ago

Profound Medical (PROF) Q2 Earnings Surpass Estimates


Profound Medical Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Profound Medical Earnings Call Transcript: Q2 2026


Profound Medical Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Profound Medical Earnings release: Q2 2026


Profound Medical Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Profound Medical Quarterly report: Q2 2026


Profound Medical Reports Second Quarter 2026 Financial Results

Thu, 06 Aug 2026 16:12:00 -0400 - 12 days ago

Profound Medical Reports Second Quarter 2026 Financial Results


Robotic Radical Prostatectomy Comes Up ‘Short' in CAPTAIN Trial

Fri, 24 Jul 2026 10:15:00 -0400 - 25 days ago

Robotic Radical Prostatectomy Comes Up ‘Short' in CAPTAIN Trial


Profound Medical Corp Annual Shareholders Meeting Transcript

2026-05-13T22:01:26.000Z - 3 months ago

Profound Medical Corp Annual Shareholders Meeting Transcript


Profound Medical Registration statement: Registration filing

May 12, 2026, 8:00 AM EDT - 3 months ago

Profound Medical Registration statement: Registration filing


Profound Medical Q1 Earnings Call Highlights

Fri, 08 May 2026 17:09:15 -0400 - 3 months ago

Profound Medical Q1 Earnings Call Highlights


Profound Medical price target lowered to $10 from $12 at Stifel

2026-05-08T12:46:30.000Z - 3 months ago

Profound Medical price target lowered to $10 from $12 at Stifel


Profound Medical Earnings Call Transcript: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Profound Medical Earnings Call Transcript: Q1 2026


Profound Medical Earnings release: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Profound Medical Earnings release: Q1 2026


Profound Medical Quarterly report: Q1 2026

May 7, 2026, 4:30 PM EDT - 3 months ago

Profound Medical Quarterly report: Q1 2026


Profound Medical Reports Strong First Quarter 2026 Financial Results

Thu, 07 May 2026 16:05:00 -0400 - 3 months ago

Profound Medical Reports Strong First Quarter 2026 Financial Results


Profound Medical Slides: Corporate presentation

May 7, 2026, 7:00 AM EDT - 3 months ago

Profound Medical Slides: Corporate presentation


Profound Medical Slides: Corporate presentation

Apr 21, 2026, 7:00 AM EDT - 4 months ago

Profound Medical Slides: Corporate presentation


Profound Medical Corp. Investigated by the Portnoy Law Firm

Thu, 09 Apr 2026 09:00:00 -0400 - 4 months ago

Profound Medical Corp. Investigated by the Portnoy Law Firm


Top 3 Health Care Stocks That Are Set To Fly In March

Fri, 20 Mar 2026 06:23:16 -0400 - 5 months ago

Top 3 Health Care Stocks That Are Set To Fly In March


Profound Medical Transcript: Status update

Mar 13, 2026, 11:30 AM EDT - 5 months ago

Profound Medical Transcript: Status update


Profound Medical (PROF) Awaits Key Clinical Data Presentation

2026-03-09T14:26:33.000Z - 5 months ago

Profound Medical (PROF) Awaits Key Clinical Data Presentation


Profound Medical (PROF) Reports Q4 Revenue Below Expectations

2026-03-05T21:59:47.000Z - 5 months ago

Profound Medical (PROF) Reports Q4 Revenue Below Expectations


Profound Medical Q4 Earnings Assessment

2026-03-05T21:30:08.000Z - 5 months ago

Profound Medical Q4 Earnings Assessment


Profound Medical Earnings Call Transcript: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Profound Medical Earnings Call Transcript: Q4 2025


Profound Medical Annual report: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Profound Medical Annual report: Q4 2025


Profound Medical Earnings release: Q4 2025

Mar 5, 2026, 4:30 PM EST - 5 months ago

Profound Medical Earnings release: Q4 2025


Profound Medical reports Q4 EPS (27c), consensus (28c)

2026-03-05T21:27:53.000Z - 5 months ago

Profound Medical reports Q4 EPS (27c), consensus (28c)


Profound Medical's Earnings: A Preview

2026-03-04T20:03:05.000Z - 5 months ago

Profound Medical's Earnings: A Preview


Profound Medical surpasses 2025 TULSA-PRO installed base goal

2026-01-12T13:36:38.000Z - 7 months ago

Profound Medical surpasses 2025 TULSA-PRO installed base goal


Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Jan 6, 2026, 7:45 AM EST - 8 months ago

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case


Profound Medical Corp. Announces Closing of Private Placement

Dec 30, 2025, 4:30 PM EST - 8 months ago

Profound Medical Corp. Announces Closing of Private Placement


Profound Medical Corp. Announces Upsize of Private Placement

Dec 24, 2025, 1:15 PM EST - 8 months ago

Profound Medical Corp. Announces Upsize of Private Placement


Profound Medical to launch AI-powered BPH module

2025-11-28T12:50:06.000Z - 9 months ago

Profound Medical to launch AI-powered BPH module

PROF


Profound Medical Slides: Investor presentation

Nov 25, 2025, 7:00 AM EST - 9 months ago

Profound Medical Slides: Investor presentation


Profound Medical reports Q3 EPS (26c), consensus (38c)

2025-11-16T10:55:05.000Z - 9 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

PROF


Profound Medical reports Q3 EPS (26c), consensus (38c)

2025-11-16T10:31:21.000Z - 9 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

PROF


Profound Medical files $150M mixed securities shelf

2025-11-13T22:10:18.000Z - 9 months ago

Profound Medical files $150M mixed securities shelf

PROF


Profound Medical reports Q3 EPS (26c), consensus (38c)

2025-11-13T21:46:00.000Z - 9 months ago

Profound Medical reports Q3 EPS (26c), consensus (38c)

PROF


Profound Medical Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Profound Medical Earnings Call Transcript: Q3 2025


Profound Medical Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Profound Medical Quarterly report: Q3 2025


Profound Medical Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Profound Medical Earnings release: Q3 2025


Profound Medical Registration statement: Registration Filing

Nov 13, 2025, 7:00 AM EST - 9 months ago

Profound Medical Registration statement: Registration Filing


Profound Medical Transcript: Stifel 2025 Healthcare Conference

Nov 11, 2025, 1:20 PM EST - 10 months ago

Profound Medical Transcript: Stifel 2025 Healthcare Conference


Profound Medical Earnings Call Transcript: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings Call Transcript: Q2 2025


Profound Medical Earnings release: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings release: Q2 2025


Profound Medical Quarterly report: Q2 2025

Aug 14, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Quarterly report: Q2 2025


Profound Medical Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings Call Transcript: Q1 2025


Profound Medical Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Earnings release: Q1 2025


Profound Medical Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Profound Medical Quarterly report: Q1 2025


Profound Medical Slides: Investor Presentation

May 3, 2025, 7:00 AM EDT - 1 year ago

Profound Medical Slides: Investor Presentation


Profound Medical Transcript: Status Update

Apr 28, 2025, 6:30 PM EDT - 1 year ago

Profound Medical Transcript: Status Update


Profound Medical Press release: Status Update

Apr 28, 2025, 6:30 PM EDT - 1 year ago

Profound Medical Press release: Status Update


Profound Medical AUA 2025 Investor Event Agenda

Apr 15, 2025, 7:45 AM EDT - 1 year ago

Profound Medical AUA 2025 Investor Event Agenda

PROF


alexpitti
alexpitti Aug. 18 at 2:44 PM
$PROF cfo resigns, new software. stock spikes
0 · Reply
BioTuesdays
BioTuesdays Aug. 17 at 3:53 PM
$PROF has announced the introduction of its latest Treatment Delivery Consol (TDC) software being deployed across Profound’s TULSA-PRO-installed base. https://biotuesdays.com/2026/08/17/profounds-new-real-time-interventional-mri-software-to-pave-the-way-for-full-tulsa-days/
0 · Reply
alexpitti
alexpitti Aug. 15 at 12:48 AM
This is so so ugly. $PROF cfo resigns immediately Friday night dump
1 · Reply
BioTuesdays
BioTuesdays Aug. 14 at 3:38 PM
$PROF has announced the launch of Let’s Huddle, a global patient community designed to empower men and their families with education, connection, and support throughout every stage of the prostate care journey. https://biotuesdays.com/2026/08/14/profound-launches-lets-huddle-a-global-community-supporting-men-through-prostate-care/
0 · Reply
Bravosatya
Bravosatya Aug. 10 at 8:26 PM
$PROF more adoption news - Doctors are talking on TV shows- https://x.com/bravosatya/status/2086911268427092413?s=46
0 · Reply
johntarlick
johntarlick Aug. 7 at 2:49 PM
$PROF All indications are that prospects continue to be bright here. but i just can't understand the little games, like trying to score credit for delayed shipments or converting the pipeline into a dollar figure, or lumping sono-alleve into the pipeline to make it look slightly bigger. Indeed, it's the first use of the verb 'dollarizing' that i've ever seen. there's already a lot of lingo on quarterly calls, and when i hear someone say 'dollarizing' with a straight face, i'm disinclined to value that expertise. why can't they just be straightforward about this stuff? the news is generally good, it may not yet be the 'hockey stick' they've long boosted, but slow and steady is also good news.
3 · Reply
Bravosatya
Bravosatya Aug. 7 at 12:13 PM
$PROF just posted an article on my thoughts on the challenges faced by $PROF . checkout my X post and follow me on X for more content. https://x.com/bravosatya/status/2085700225662873759?s=46
0 · Reply
Bravosatya
Bravosatya Aug. 6 at 11:01 PM
$PROF if you guys missed today’s conference call - I have summarized my key takeaways of the call on my X account . Please check and follow for more updates. I have been following and posting on $PROF for a longtime now. I also posted on Q2 Earnings Report. https://x.com/bravosatya/status/2085500786822488132?s=46
1 · Reply
alexpitti
alexpitti Aug. 6 at 10:53 PM
$PROF bad naughty report
0 · Reply
alexpitti
alexpitti Aug. 6 at 10:52 PM
$DCTH did well $RCEL did well $APYX did fine $SI did spectacularly. $PROF did things we don't want to say lol
0 · Reply
EarningsInsider
EarningsInsider Aug. 6 at 10:39 PM
https://www.marketbeat.com/earnings/reports/2026-8-6-profound-medical-corp-stock/ $PROF Profound Medical Earnings Transcript
0 · Reply
LeaderStockHunter
LeaderStockHunter Aug. 6 at 9:09 PM
$PROF revenue up but the numbers are tiny. $3M shipment pulled forward. H2 execution is the real test. Too early.
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Aug. 6 at 8:43 PM
$PROF Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.26 up 50.00% YoY • Reported revenue of $2.48M up 12.30% YoY
0 · Reply
ijustwantafarm
ijustwantafarm Aug. 5 at 8:10 PM
$PROF anyone care about the call volume Monday and today?
0 · Reply
alexpitti
alexpitti Aug. 3 at 8:19 PM
$PROF I'm pretty sure the penis gets larger again. that's just temporary shortening
1 · Reply
alexpitti
alexpitti Aug. 3 at 7:40 PM
$PROF getting a little expensive even if penis length isn't shortened
0 · Reply
JFais
JFais Aug. 3 at 2:51 PM
$PROF (NP) Looks like this Playbook setup ran without me (stalking prior with desire to accumulate dips $5.50 - $6 range) Another medical device idea from Osmium in our Chat (3+ decades working in the space, $TMDX in the teens another one from him) Prior rationale below fwiw
0 · Reply
JFais
JFais Jul. 25 at 12:00 AM
Os on $PROF 😂😂
0 · Reply
BioTuesdays
BioTuesdays Jul. 24 at 2:40 PM
$PROF The title of Profound Medical’s press release today, “Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial,” playfully set the tone for its reporting of a sensitive subject: penile length secondary endpoint data from the Level 1 post-market CAPTAIN randomized controlled trial comparing its TULSA Procedure with robotic radical prostatectomy (robotic RP) in men with organ-confined, intermediate-risk, Gleason Score 7 (Grade Group 2 and 3) prostate cancer. https://biotuesdays.com/2026/07/24/incisionless-tulsa-procedure-for-prostate-cancer-demonstrated-statistically-significant-superior-penile-length-preservation-compared-to-robotic-radical-prostatectomy-at-1-month/
0 · Reply
focafoca99
focafoca99 Jul. 24 at 2:37 PM
$PROF presented new CAPTAIN trial data showing the TULSA Procedure preserved penile length versus robotic prostatectomy.
0 · Reply
BioTuesdays
BioTuesdays Jul. 15 at 6:20 PM
$PROF announced that its MRI-guided, AI-powered, Robotically-Driven and Incisionless TULSA Procedure will be highlighted in several presentations by leading physicians at the upcoming Society of Robotic Surgery (“SRS”) Annual Meeting to be held in Fort Lauderdale, FL, July 23-26. https://biotuesdays.com/2026/07/15/profound-medicals-autonomous-robotics-and-incisionless-surgery-to-have-strong-presence-at-srs2026/
0 · Reply
prismmarketview
prismmarketview Jul. 15 at 3:51 PM
$PROF #ProfoundMedical will have a major footprint at SRS2026, showcasing MRI‑guided, robotically controlled TULSA‑PRO as an incision‑free prostate ablation option. This is imaging‑driven robotics, not just another da Vinci clone. #PROF #PRN #SRS2026 #MedTech https://prismmarketview.com/profound-medical-uses-srs2026-to-push-its-no-incision-robotics-story/
0 · Reply